Columbia Care
213 Low Library 535 W 116th St, New York City, New York, 10027, United States
Overview
Columbia Care is a patient-center healthcare company setting the standard of care for medical marijuana. Among the many focus areas, through its operating subsidiaries located throughout the United States, Columbia Care is among the premier providers of alternative healthcare products and services for qualifying patients offering a better, natural way to eliminate suffering and improve patient lives. The company’s primary goal is to deliver the best standard of care, products, and experience in a compliant and comforting environment - one patient at a time. Columbia Care is committed to being a leader in each of its focus areas by prioritizing its patients’, regulators’ and customer needs first and operating disciplined subsidiaries that maintain four principles: compliance, innovation, social responsibility, and education - consistently exceeding patients’, partners’ and regulators’ expectations. In every jurisdiction in which it operates, the company offers financial and philanthropic support to work in partnership with local leaders, law enforcement, medical/healthcare providers, and patient and community advocacy groups to ensure its neighbors benefit directly from its involvement in their communities. The company’s team, led by its executive team CEO, Nicholas Vita, and President Bob Mayerson along with the Board of Directors chaired by Non-Executive Chairman and Shareholder, Michael Abbott, is comprised of experts from every related discipline including pharmacy, clinical research, medicine, security, community outreach, technology, finance, legal/compliance, government, education, and retail.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 7
Sector focus
- Cannabis
- Health Care
- Medical
Investment portfolio
- The Nue Co.
Participated · Series A · Jun 2019
The Nue Co develops personalised supplement formulas delivered via capsules, liquid meal supplements, and fragrance, sold through subscription plans. Its supplement plans are organised by categories including energy, gut health, immunity, skin, and sleep. The company says it takes a personalised approach to health by investing in data capture to understand customers’ bodies, guts, and sleep patterns. Jules Miller, founder and CEO, said the raise will allow the company to understand customers better and have a bigger impact through more efficient products and routines. The startup is British-founded, currently headquartered in the US, and counts the UK as its biggest market. The company raised funding to accelerate its personalised-product strategy.